Skip to content

Lung Cancer Patients and Parent-child Interaction Experience and Process

Lung Cancer Patients and Parent-child Interaction Experience and Process

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06823505
Enrollment
109
Registered
2025-02-12
Start date
2023-12-17
Completion date
2025-01-21
Last updated
2025-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer Patients, Parent-child Interaction

Brief summary

Type of study: The goal of this observational study is to explore the relationship between patients with advanced lung cancer and their parent-child interactions during the treatment process, and to understand the impact of the degree of self-differentiation of parents with advanced lung cancer on the physical and mental health of their children. The main questions it aims to answer are: 1. To explore the post-illness adjustment process of patients with advanced lung cancer and the changes in the parent-child relationship among adolescents. 2. To explore the changes in demographic factors-self-belief, mental health, and self-efficacy among patients with advanced lung cancer-and the parent-child relationship among adolescents. 3. Explore the family resilience of patients with advanced lung cancer - family peer relationships, and the interaction between parent-child relationships among adolescents.

Detailed description

This study explores the relationship between late-stage lung cancer patients and their parent-child interactions during the treatment process, and understands the impact of the degree of self-differentiation of parents with late-stage lung cancer on their children's physical and mental health.

Interventions

Using the Depression Scale (CES-D), Cancer Self-Efficacy Scale (CASE), Family Peer Relationship Questionnaire (FPRQ), Family Resilience Scale (FRAS) and Parent-Child Relationship Quality Scale

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Observational model
FAMILY_BASED
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
40 Years to 64 Years
Healthy volunteers
Yes

Inclusion criteria

1. Patients with advanced lung cancer aged 40 to 64 years (mid-adulthood). 2. There are lung cancer patients in the family who are teenagers aged 10 to 19 years old. 3. Those who voluntarily participate in this study. 4. Voluntary participants can express themselves orally and in handwriting.

Exclusion criteria

1. Single lung cancer patients over 65 years old. 2. Lung cancer patients under 40 years old. 3. Patients diagnosed with early-stage lung cancer. 4. Those who have cognitive impairment and are unable to understand the problem. 5. Those who are unable to express and respond to questions.

Design outcomes

Primary

MeasureTime frameDescription
Parent-child interactionone yearsThe interaction between patients with advanced lung cancer and their parents and children during the treatment process
Center for Epidemiological Studies Depression Scaleone yearsThe CES-D scale is designed to measure an individual's depression level, covering multiple aspects such as depressed mood, guilt, helplessness, decreased appetite, sleep disturbance and psychomotor retardation, with a total of 20 items. The subjects evaluated the frequency of each symptom in the past week using a four-point scale (1 point: never or rarely; 4 points: often). Studies have shown that CES-D has good internal consistency (α=0.85) (Conerly et al., 2002; Given et al., 2004) and reliability (Cronbach's alpha \> 0.85) in cancer patients (Hann et al., 2004). al., 1999) , and therefore can effectively assess the level of depression in cancer patients. In short, the CES-D is a validated tool for assessing depression in cancer patients.

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026